Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Pathology: Research and Practice

Volume  9, Issue 2 (Part-1), May-August 2020, Pages 111-116
 

Original Article

A Clinicopathologic Study of Bone Marrow involvement in Hodgkin Disease

Sushma Belurkar1, Seemitr Verma2, Miriya Thomas3, Ruchee Khanna4

1,4Associate Professor, 2Assistant Professor, 3Junior Resident, Department of Pathology, Basic Sciences Building, Kasturba Medical College, MAHE, Manipal, Karnataka 576104, India.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.9220.19

Abstract

Introduction: Bone marrow involvement is not very common in Hodgkin Lymphoma (HL) and when present has an implication on the treatment strategies and prognosis of the patient. This study evaluates the various bone marrow changes seen in Hodgkins Lymphoma. Methods: This is a one year retrospective study carried out in the cilinical laboratory of Kasturba Hospital, Manipal, India. All the patients diagnosed as HL on lymph node biopsy in whom bone marrow aspirate and biopsy were done were included in the study. Results: A total of 24 patients of HL were included in the study. Bone marrow infiltration was seen in only 2
patients (8.3%). 4 cases (16.6%) showed Hodgkin associated changes in the bone marrow whereas remaining 18 patients (75%) did not show any changes in the bone marrow. The cases with infiltration showed presence of mononuclear variant of Reed Sternberg cells with increased eosinophils and lymphocytes. Hodgkin associated changes included increased eosinophils, monocytes and histiocytes, dyspoeticmegakaryocytes, presence of atypical lymphocytes and increased activated histiocytes but absence of RS cells or its variants. 18 patients received the ABVD chemotherapy regimen whereas 6 patients did not receive treatment in our hospital. Out of the 18 patients
only one patient relapsed in one year follow up. Conclusion: The incidenceof BMI is rare in HL as compared to Non Hodgkin lymphoma. The BMI can be in the form of frank infiltration or non infiltrative Hodgkin associated changes. The relationship between Hodgkin associated changesand prognosis of the disease is not yet clearly understood. However bone marrow examination is a must in all cases of HL to aid in appropriate staging and to decide on treatment modifications required.

Keywords: Hodgkin lymphoma; Bone marrow; Reed Sternberg cell; Histiocytes.
 


Corresponding Author : Sushma Belurkar